Global Artificial Organ And Bionics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

An artificial organ is a device which is man-made and is integrated or implanted into the human in order to restore target function via the replacement of a natural organ. The material used to develop body interfaces or implants are known as biomaterials. Processing abilities that are not occurring naturally can be constructed and installed with the help of artificial organs and replaced function need not be in the context of life support but generally, it is to support life.
According to our (Global Info Research) latest study, the global Artificial Organ And Bionics market size was valued at USD 25000 million in 2022 and is forecast to a readjusted size of USD 35540 million by 2029 with a CAGR of 5.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America held the largest share in the artificial organ or medical bionic implant space, followed by Europe. However, the market is emerging due to the rise in population coupled with awareness among the players and the patients. Growing income levels, increasing healthcare expenditure, less competition than mature countries are the factors which are responsible for increasing the market playersﾒ interest in emerging markets. Asia-Pacific region is expected to rise and hold a larger share of this market in near future because of the rise in medical tourism, improvement in healthcare infrastructure and others.
This report is a detailed and comprehensive analysis for global Artificial Organ And Bionics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Artificial Organ And Bionics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Artificial Organ And Bionics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Artificial Organ And Bionics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Artificial Organ And Bionics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Organ And Bionics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Organ And Bionics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abiomed Inc., Asahi Kasei Kuraray Medical Co. Ltd., Thoratec Corporation, WorldHeart Corp. and Gambro AB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Artificial Organ And Bionics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Mechanical Bionics
    Electronic Bionics
Market segment by Application
    Hospital
    Clinic
Market segment by players, this report covers
    Abiomed Inc.
    Asahi Kasei Kuraray Medical Co. Ltd.
    Thoratec Corporation
    WorldHeart Corp.
    Gambro AB
    Biomet Inc.
    Cochlear Ltd.
    Berlin Heart Gmbh
    Ekso Bionics
    Medtronic Inc.
    Lifenet Health
    Heartware International Inc.
    Jarvik Heart Inc.
    Walk Inc.
    Ossur
    Boston Scientific Corporation
    Sorin S.P.A.
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Organ And Bionics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Organ And Bionics, with revenue, gross margin and global market share of Artificial Organ And Bionics from 2018 to 2023.
Chapter 3, the Artificial Organ And Bionics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Artificial Organ And Bionics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Organ And Bionics.
Chapter 13, to describe Artificial Organ And Bionics research findings and conclusion.